FSH promoted fat accumulation in aging and fat redistribution from subcutaneous to visceral fat but appeared to play no role in the progression of NAFLD because there was no correlation to fibrosis. Here, BRD2 is linked to metabolic dysfunction-associated steatotic liver disease.